Bjorn B. Thaler - Nov 1, 2022 Form 4 Insider Report for 1Life Healthcare Inc (ONEM)

Role
Chief Financial Officer
Signature
/s/ Ivy Tseng, Attorney-in-Fact for Bjorn B. Thaler
Stock symbol
ONEM
Transactions as of
Nov 1, 2022
Transactions value $
-$95,524
Form type
4
Date filed
11/3/2022, 05:15 PM
Previous filing
Oct 12, 2022
Next filing
Nov 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONEM Common Stock Options Exercise $82.6K +10.4K +71.95% $7.93 24.9K Nov 1, 2022 Direct
transaction ONEM Common Stock Sale -$178K -10.4K -41.84% $17.10 14.5K Nov 1, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONEM Stock Option (Right to Buy) Options Exercise $0 -10.4K -16.67% $0.00 52.1K Nov 1, 2022 Common Stock 10.4K $7.93 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.
F2 This transaction was executed in multiple trades at prices ranging from $17.10 to $17.105. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the first anniversary of the vesting commencement date; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years, subject to the reporting person's continuous service as of each such date.